{
    "clinical_study": {
        "@rank": "154829", 
        "arm_group": [
            {
                "arm_group_label": "Exparel", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Marcaine", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The Investigators aim to study the efficacy of Exparel as compared to Marcaine, taking into\n      account pain control, narcotic consumption, narcotic-related side effects, outcomes\n      measures, and patient satisfaction. Moreover, the Investigators plan to perform cost-benefit\n      analysis to evaluate whether use of Exparel decreases analgesic consumption, duration of\n      hospital stay and the need for physical therapy postoperatively, therefore, offsetting its\n      higher price in comparison with Marcaine."
        }, 
        "brief_title": "Comparison of Two Periarticular Injection Medications for Adjunctive Pain Management Following Total Knee Arthroplasty (TKA)", 
        "condition": "Total Knee Arthroplasty", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All patients at least 18 years old who have primary unilateral TKA for osteoarthritis\n        performed at Thomas Jefferson University Hospital.\n\n        Exclusion Criteria:\n\n          -  American Society of Anesthesiologist (ASA) score of 4 or higher\n\n          -  Hepatic disease (contraindication for acetaminophen)\n\n          -  Renal disease (contraindication for NSAIDs)\n\n          -  Any contraindication for oxycodone, ketorolac, epinephrine, pregabalin, gabapentin,\n             hydromorphone, Tramadol, morphine or other narcotics that are considered as part of\n             routine postoperative pain control protocol\n\n          -  Fibromyalgia\n\n          -  Any contraindication for intrathecal opioid injection\n\n          -  History of substance abuse during the last 2 years\n\n          -  History of allergy to amide compounds\n\n          -  Current consumption of monoaminoxidase (MAO) inhibitors and tricyclic antidepressant\n             (TCA) medications\n\n          -  Allergy to metabisulfite compounds\n\n          -  Chronic use of opioid medications in the month prior to surgery (leads to opioid\n             tolerance and/or opioid-induced hyperalgesia)\n\n          -  Body weight<50 Kg, BMI>40 Kg/m2\n\n          -  History of hypotension\n\n          -  Patients with any surgery related complication in the first 4-6 weeks following TKA,\n             such as infection or mechanical failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "February 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02060591", 
            "org_study_id": "14PAR01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Exparel", 
                "intervention_name": "Exparel", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Marcaine", 
                "intervention_name": "Marcaine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Bupivacaine"
        }, 
        "lastchanged_date": "February 11, 2014", 
        "location": {
            "contact": {
                "email": "tiffany.morrison@rothmaninstitute.com", 
                "last_name": "Tiffany Morrison, MS, CCRP", 
                "phone": "267-339-7818"
            }, 
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19107"
                }, 
                "name": "Rothman Institute"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_contact": {
            "email": "tiffany.morrison@rothmaninstitute.com", 
            "last_name": "Tiffany Morrison, MS, CCRP", 
            "phone": "267-339-7818"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "2. Measure pain intensity score (pre and post-operatively) by visual analogue scale (VAS) method", 
            "safety_issue": "No", 
            "time_frame": "Within first 30 days post-operatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02060591"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Rothman Institute Orthopaedics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rothman Institute Orthopaedics", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}